直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • 実績

デューディリジェンス

About

デューディリジェンスでリスクを査定し、自信をもって前進する

待ったなしのプレッシャーのかかる合併、買収、業務提携、及び投資取引においては、正確かつ包括的な知的財産評価を得ることが極めて重要です。係属中又は潜在的な訴訟の結果の可能性、知的財産契約の譲渡性、及び知的財産権の保護範囲や所有権、等は検討すべき課題の一例です。

弊所は、様々な技術に関する深い理解をもち知的財産法に精通しており、企業の知財取引において浮上する様々な課題に迅速に対応すべく支援します。また、発明者からの質問に真摯かつ正確な答えを示し、契約書の作成にあたってはリスクを適切に配分します。争点となっているIP資産の分析では、公平な取引となることを念頭に置き、ターゲットを絞り洗練された分析を行います。

弊所は、エクソン社とモービル社の合併のような複雑な案件から、後の資金調達を視野に入れたまだ立ち上げ段階の革新的なバイオテック企業のインライセンス契約の分析まで、デューディリジェンスを実行し、成功に導いています。弊所の規模、技術的バックグラウンド、及び経験をもって適したチームを結成し、主な争点をいち早く特定し、リスクを緩和するオプションを提案し、さらにクライアントの取引上の立場を強いものにする戦略を提示します。理想的には、デューディリジェンスは交渉の最初の段階で行われ、これにより、IPポートフォリオの価値の合理的な分析を行う時間と、取引に影響し得る課題に対して補正的な処理を行う時間を確保することができます。

Everyone in this practice

実績

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Assessed IP issues as part of due diligence efforts in $45 million acquisition deal focused on DNA writing via CRISPR.
Helped a global chemical company conduct due diligence when acquiring intellectual property rights in nanotechnology

Oversaw due diligence for one of the world’s largest chemical companies during the acquisition of another company, including overseeing the mapping and analysis of the target’s patent portfolio and analyzing potential infringement by competitors.

Working with innovators in surveillance and home monitoring technologies
Finnegan works with clients developing surveillance and home monitoring technologies, where images and videos are captured and transmitted for real-time viewing and monitoring anywhere there is Internet access. We help these clients build portfolios around all technology areas in surveillance, defend against infringement accusations, and perform risk analysis before products are launched in the market.
Protecting business-method patents for a travel-related company
We represented a major travel-related company in securing worldwide patent protection on a diverse portfolio of software and business-method–related inventions. We advised and defended the client on various allegations of patent infringement and third-party claims for indemnification against infringement allegations. We also assisted in establishing company patent and other IP policies, conducting due diligence and patent clearance investigations, and managing the entire IP portfolio.
Finnegan helps Rambus acquire Cryptography Research Inc. for $350 million
In the fields of memory technology, cryptography, and other new ventures, we help Rambus obtain patent rights from patent offices worldwide and have taken significant roles in assessing intellectual property issues as part of acquisition due diligence efforts and other strategic counseling projects. For example, in connection with Rambus’ acquisition of Cryptography Research, Inc. (CRI), Finnegan conducted an extensive IP due diligence. The deal was valued at over $350 million and involved the acquisition of the CRI and its IP assets focused on cryptographic technologies, such as protective measures against differential power analysis and other ways of protecting encrypted systems.
Ensuring the broadest possible patent protection and expansion support
We provide in-depth patent prosecution and counseling services for one of the world's leading information management companies. Our service includes preparing patent applications directed to novel methods and systems for storing, protecting, and managing information with a particular focus on records management and data protection and recovery. In addition, we have provided due diligence for our client’s mergers and acquisitions, to assist it in achieving its strategic growth goals.

More

Insights

Lecture

2025 IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course

March 6-7, 2025

Webinar

Workshop

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 2, 2024

Cambridge

Conference

2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities

March 20, 2024

Boston

Lecture

IP (Intellectual Property) Due Diligence & Freedom to Operate in Practice Training Course

March 7-8, 2024

Virtual

Articles

White House Unveils New Order to Protect Bulk Data

March 6, 2024

Articles

How to Avoid Common Pitfalls and Protect IP in Today’s Life Sciences Industry Joint Ventures

February 29, 2024

More

最新情報

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Award/Ranking

Finnegan Partner Adriana Burgy Named a 2025 BTI Client Service All-Star

August 21, 2025

Commentary

Under the Evolving Intellectual Property Landscape in the U.S. and China, How Chinese Tech Companies Address Overseas Challenges

April 11, 2024

Commentary

Too Many Cooks: Inventorship an Increasing Problem for Patent Counsel

November 21, 2023

Justin A. Hendrix

IP Legal Era Magazine Names Finnegan Global Law Firm of the Year

November 18, 2016

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP